Employees Retirement System of Texas’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-42,000
Closed -$1.61M – 378
2022
Q2
$1.61M Hold
42,000
– – 0.02% 561
2022
Q1
$1.74M Hold
42,000
– – 0.02% 583
2021
Q4
$1.59M Hold
42,000
– – 0.02% 581
2021
Q3
$1.38M Buy
42,000
+24,000
+133% +$935K 0.02% 620
2021
Q2
$1.21M Hold
18,000
– – 0.01% 642
2021
Q1
$1.02M Hold
18,000
– – 0.01% 666
2020
Q4
$1.47M Hold
18,000
– – 0.02% 543
2020
Q3
$1.28M Buy
+18,000
New +$1.4M 0.02% 598

Other funds holding AXSM

Employees Retirement System of Texas's AXSM Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of Axsome Therapeutics (AXSM) in Q3 2022, closing a stake of 42,000 shares — an estimated $1.61M sold.

Employees Retirement System of Texas first reported a position in AXSM in Q3 2020 and held it in 8 quarters. The position peaked at $1.74M in Q1 2022. 187 funds tracked by Wall St. Rank hold AXSM as of Q3 2022.

  • Employees Retirement System of Texas reported no remaining Axsome Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Employees Retirement System of Texas sold 42,000 Axsome Therapeutics shares in Q3 2022, an estimated $1.61M.
  • Employees Retirement System of Texas first reported a position in Axsome Therapeutics in Q3 2020 and held it in 8 quarters.
  • Employees Retirement System of Texas's Axsome Therapeutics position peaked at $1.74M in Q1 2022.
  • 187 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.